New Parkinson's pill offers significant symptom relief in trial

Summarised from 2 outlets · Updated 7 Oct, 22:37 · Archive

A new drug called solengepras reduced daily 'off' time symptoms in Parkinson's patients by 37 minutes.

A new daily pill called solengepras has demonstrated significant benefits in treating Parkinson's disease symptoms. Trial results found that patients on the drug experienced 37 minutes less 'off' time each day, the period when dopamine drugs fail to work properly. The drug was shown to reduce the stiffness, slowness and tremors associated with the condition, with fewer side-effects reported.

The breakthrough represents a potential major new class of treatment for Parkinson's in recent decades. Both outlets report the drug offers hope for patients whose symptoms are not adequately controlled by existing dopamine therapies.

How it is being reported

• Daily pill for Parkinson's disease raises hopes patients could see first major new class of treatment in decadesThe drug significantly reduced the amount of time patients spent struggling with the stiffness, slowness and tremors associated with the condition.Daily Mail · 7 Oct, 22:19
• Major Parkinson’s breakthrough as new pill offers hope of treating symptoms and has fewer side-effectsTrial found patients on solengepras had 37 minutes less ‘off’ time each day when dopamine drugs failed to work properlyThe Independent · 7 Oct, 16:57

In this story: solengepras

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem